Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 36 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $35.747 million which beat the analyst consensus estimate of $35.224 million by 1.48 percent. This is a 9.77 percent increase over sales of $32.564 million the same period last year.